ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,672.95
0.41%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Portage Biotech Inc (PRTG)

  7. Portage Biotech Inc (PRTG) News

PRTG Portage Biotech Inc

0.2402
0.0032 (1.35%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Portage Biotech Inc PRTG NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0032 1.35% 0.2402 14:00:03
Open Price Low Price High Price Close Price Previous Close
0.2418 0.23 0.2642 0.2402 0.237
more quote information »

Recent News

Date Time Source Heading
12/4/202422:01GLOBEPortage Biotech Announces Plans to Expand its Evaluation of..
26/3/202423:01GLOBEPortage Biotech Completes Monetization of Intensity..
09/3/202409:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/3/202409:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202409:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/2/202409:10GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
15/2/202407:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/1/202409:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202400:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202400:00GLOBEPortage Biotech Reports Business and Strategic Update
02/12/202308:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/11/202308:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
29/11/202308:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202308:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202322:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202322:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
08/11/202308:50EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/11/202300:01GLOBEPortage Biotech Presents Updates on its iNKT and Adenosine..
01/11/202307:05EDGAR2Form F-1 - Registration statement for certain foreign..
29/9/202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/9/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202306:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202307:12EDGAR2Form 20-F - Annual and transition report of foreign private..

Your Recent History

NASDAQ
PRTG
Portage Biotech
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved